Long-term quality of life after treatment in sinonasal malignancy: A prospective, multicenter study.
head and neck cancer
quality of life
sinonasal cancer
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
revised:
10
04
2023
received:
15
03
2023
accepted:
18
04
2023
pubmed:
21
4
2023
medline:
21
4
2023
entrez:
21
04
2023
Statut:
ppublish
Résumé
Quality of life (QOL) for individuals with sinonasal malignancy (SNM) is significantly under-studied, yet it is critical for counseling and may impact treatment. In this study we evaluated how patient, treatment, and disease factors impact sinonasal-specific and generalized QOL using validated metrics in a large cohort over a 5-year posttreatment time frame. Patients with SNM who underwent definitive treatment with curative intent were enrolled in a prospective, multisite, longitudinal observational study. QOL was assessed using the 22-item Sino-Nasal Outcome Test (SNOT-22) and University of Washington Quality of Life Questionnaire (UWQOL) instruments at pretreatment baseline and multiple follow-ups through 5 years posttreatment. Multivariable modeling was used to determine demographic, disease, and treatment factors associated with disease-specific and generalized physical and social/emotional function QOL. One hundred ninety-four patients with SNM were analyzed. All QOL indices were impaired at pretreatment baseline and improved after treatment. SNOT-22 scores improved 3 months and UWQOL scores improved 6 to 9 months posttreatment. Patients who underwent open compared with endoscopic tumor resection had worse generalized QOL (p < 0.001), adjusted for factors including T stage. Pterygopalatine fossa (PPF) involvement was associated with worse QOL (SNOT-22, p < 0.001; UWQOL Physical dimension, p = 0.02). Adjuvant radiation was associated with worse disease-specific QOL (p = 0.03). Neck dissection was associated with worse generalized physical function QOL (p = 0.01). Positive margins were associated with worse generalized social/emotional function QOL (p = 0.01). Disease-specific and generalized QOL is impaired at baseline in patients with SNM and improves after treatment. Endoscopic resection is associated with better QOL. PPF involvement, adjuvant radiation, neck dissection, and positive margins were associated with worse QOL posttreatment.
Sections du résumé
BACKGROUND
BACKGROUND
Quality of life (QOL) for individuals with sinonasal malignancy (SNM) is significantly under-studied, yet it is critical for counseling and may impact treatment. In this study we evaluated how patient, treatment, and disease factors impact sinonasal-specific and generalized QOL using validated metrics in a large cohort over a 5-year posttreatment time frame.
METHODS
METHODS
Patients with SNM who underwent definitive treatment with curative intent were enrolled in a prospective, multisite, longitudinal observational study. QOL was assessed using the 22-item Sino-Nasal Outcome Test (SNOT-22) and University of Washington Quality of Life Questionnaire (UWQOL) instruments at pretreatment baseline and multiple follow-ups through 5 years posttreatment. Multivariable modeling was used to determine demographic, disease, and treatment factors associated with disease-specific and generalized physical and social/emotional function QOL.
RESULTS
RESULTS
One hundred ninety-four patients with SNM were analyzed. All QOL indices were impaired at pretreatment baseline and improved after treatment. SNOT-22 scores improved 3 months and UWQOL scores improved 6 to 9 months posttreatment. Patients who underwent open compared with endoscopic tumor resection had worse generalized QOL (p < 0.001), adjusted for factors including T stage. Pterygopalatine fossa (PPF) involvement was associated with worse QOL (SNOT-22, p < 0.001; UWQOL Physical dimension, p = 0.02). Adjuvant radiation was associated with worse disease-specific QOL (p = 0.03). Neck dissection was associated with worse generalized physical function QOL (p = 0.01). Positive margins were associated with worse generalized social/emotional function QOL (p = 0.01).
CONCLUSION
CONCLUSIONS
Disease-specific and generalized QOL is impaired at baseline in patients with SNM and improves after treatment. Endoscopic resection is associated with better QOL. PPF involvement, adjuvant radiation, neck dissection, and positive margins were associated with worse QOL posttreatment.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2030-2042Subventions
Organisme : Natlie A. Cole-Reagins Foundation
Organisme : International Society of Inflammation and Allergy of the Nose
Informations de copyright
© 2023 ARS-AAOA, LLC.
Références
Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34(6):877-885. doi:10.1002/HED.21830
Beswick DM, Holsinger FC, Kaplan MJ, et al. Design and rationale of a prospective, multi-institutional registry for patients with sinonasal malignancy. Laryngoscope. 2016;126(9):1977-1980. doi:10.1002/LARY.25996
Wang EW, Zanation AM, Gardner PA, et al. ICAR: endoscopic skull-base surgery. Int Forum Allergy Rhinol. 2019;9(S3):S145-S365. doi:10.1002/alr.22326
Ansa B, Goodman M, Ward K, et al. Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973 to 2009. Cancer. 2013;119(14):2602-2610. doi:10.1002/CNCR.28108
Youlden DR, Cramb SM, Peters S, et al. International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol. 2013;37(6):770-779. doi:10.1016/J.CANEP.2013.09.014
Issa K, Ackall F, Jung SH, et al. Survival outcomes in sinonasal carcinoma with neuroendocrine differentiation: a NCDB analysis. Am J Otolaryngol. 2021;42(2). doi:10.1016/J.AMJOTO.2020.102851
Husain Q, Joshi RR, Cracchiolo JR, et al. Surgical management patterns of sinonasal malignancy: a population-based study. J Neurol Surg B Skull Base. 2019;80(4):371-379. doi:10.1055/S-0038-1675233
Gore MR. Survival in sinonasal and middle ear malignancies: a population-based study using the SEER 1973-2015 database. BMC Ear Nose Throat Disord. 2018;18(1). doi:10.1186/S12901-018-0061-4
Oxford Centre for Evidence-Based Medicine (CEBM) - levels of evidence (March 2009). Accessed November 4, 2022. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009
Philips R, Agarwal A, Chitguppi C, et al. Quality of life outcomes in patients with sinonasal malignancy after definitive treatment. Laryngoscope. 2021;131(7):E2212-E2221. doi:10.1002/lary.29339
Tyler MA, Mohamed ASR, Smith JB, et al. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope. 2020;130(1):86-93. doi:10.1002/lary.27849
Glicksman JT, Parasher AK, Brooks SG, et al. Sinonasal quality of life after endoscopic resection of malignant sinonasal and skull base tumors. Laryngoscope. 2018;128(4):789-793. doi:10.1002/lary.26833
Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol. 2009;34(5):447-454. doi:10.1111/j.1749-4486.2009.01995.x
Sarris CE, Little AS, Kshettry VR, et al. Assessment of the validity of the sinonasal outcomes test-22 in pituitary surgery: a multicenter prospective trial. Laryngoscope. 2021;131(11):E2757-E2763. doi:10.1002/LARY.29711
Hassan SJ, Weymuller EA. Assessment of quality of life in head and neck cancer patients. Head Neck. 1993;15(6):485-496. doi:10.1002/HED.2880150603
Rogers SN, Lowe D, Yueh B, Weymuller EA. The physical function and social-emotional function subscales of the University of Washington quality of life questionnaire. Arch Otolaryngol - Head Neck Surg. 2010;136(4):352-357. doi:10.1001/archoto.2010.32
Deshields TL, Potter P, Olsen S, Liu J. The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer. 2014;22(4):1089-1096. doi:10.1007/S00520-013-2049-3/TABLES/5
Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. JNCI J Natl Cancer Inst. 2000;92(17):1422-1429. doi:10.1093/JNCI/92.17.1422
Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. JNCI J Natl Cancer Inst. 2002;94(1):39-49. doi:10.1093/JNCI/94.1.39
Phillips KM, Hoehle LP, Caradonna DS, Gray ST, Sedaghat AR. Minimal clinically important difference for the 22-item sinonasal outcome test in medically managed patients with chronic rhinosinusitis. Clin Otolaryngol. 2018;43(5):1328-1334. doi:10.1111/COA.13177
McDowell L, Gough K, King M, Corry J, Rischin D. Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer - A review of the literature and PRO methodology. Oral Oncol. 2021;118:105309. doi:10.1016/J.ORALONCOLOGY.2021.105309
El-Deiry MW, Futran ND, McDowell JA, Weymuller EA, Yueh B. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Neck Surg. 2009;135(4):380-384. doi:10.1001/ARCHOTO.2009.18
Vartanian JG, Lopes Carvalho A, Yueh B, et al. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Neck Surg. 2004;130(10):1209-1213. doi:10.1001/ARCHOTOL.130.10.1209
Binenbaum Y, Amit M, Billan S, Cohen JT, Gil Z. Minimal clinically important differences in quality of life scores of oral cavity and oropharynx cancer patients. Ann Surg Oncol. 2014;21(8):2773-2781. doi:10.1245/S10434-014-3656-Z/TABLES/4
Sharma RK, Irace AL, Overdevest JB, Turner JH, Patel ZM, Gudis DA. Association of race, ethnicity, and socioeconomic status with esthesioneuroblastoma presentation, treatment, and survival. OTO open. 2022;6(1). doi:10.1177/2473974X221075210
London AO, Gallagher LW, Sharma RK, et al. Impact of race, ethnicity, and socioeconomic status on nasopharyngeal carcinoma disease-specific and conditional survival. J Neurol Surg B Skull Base. 2021;83(5). doi:10.1055/S-0041-1741111
Sharma RK, Schlosser RJ, Beswick DM, et al. Racial and ethnic disparities in paranasal sinus malignancies. Int Forum Allergy Rhinol. 2021;11(11):1557-1569. doi:10.1002/ALR.22816
Patel ZM, Li J, Chen AY, Ward KC. Determinants of racial differences in survival for sinonasal cancer. Laryngoscope. 2016;126(9):2022-2028. doi:10.1002/LARY.25897
Farhood Z, Schlosser RJ, Pearse ME, Storck KA, Nguyen SA, Soler ZM. Twenty-two-item sino-nasal outcome test in a control population: a cross-sectional study and systematic review. Int Forum Allergy Rhinol. 2016;6(3):271-277. doi:10.1002/ALR.21668
McDonald C, Lowe D, Bekiroglu F, Schache A, Shaw R, Rogers SN. Health-related quality of life in patients with T1N0 oral squamous cell carcinoma: selective neck dissection compared with wait and watch surveillance. Br J Oral Maxillofac Surg. 2019;57(7):649-654. doi:10.1016/J.BJOMS.2019.05.021
Laverick S, Lowe D, Brown JS, Vaughan ED, Rogers SN. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Neck Surg. 2004;130(2):149-154. doi:10.1001/ARCHOTOL.130.2.149
Galloni C, Locatello LG, Bruno C, Cannavicci A, Maggiore G, Gallo O. The role of elective neck treatment in the management of sinonasal carcinomas: a systematic review of the literature and a meta-analysis. Cancers. 2021;13(8). doi:10.3390/CANCERS13081842
Woo HJ, Hwang PH, Kaplan MJ, Choby G. Clinical characteristics and prognostic factors of malignant tumors involving pterygopalatine fossa. Head Neck. 2020;42(2):281-288. doi:10.1002/HED.26000
Battaglia P, Turri-Zanoni M, Lepera D, et al. Endoscopic transnasal approaches to pterygopalatine fossa tumors. Head Neck. 2016;38(S1):E214-E220. doi:10.1002/HED.23972